Figure 7. Generalization value of AHNAK2 in pan-cancer. (A) Comparison of AHNAK2 mRNA expression between pan-cancer cancerous and paracancerous tissues based on GEPIA. (B) Associations between AHNAK2 expression and stage across human cancers based on TISIDB. (C) Associations between AHNAK2 expression and overall survival across human cancers based on TISIDB. K-M survival analysis of (D) BLCA, (E) GBM, (F) LUAD, (G) MESO, (H) PAAD, (I) SKCM, (J) UVM, and (K) pan-cancer in the low AHNAK2 and high AHNAK2 groups based on TISIDB and GEPIA. NS: no significance.